Douglas Richman

Title(s)Recall Hcomp, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Dartmouth College, Hanover, NHA.B1965English
    Stanford University , Stanford, CAM.D.1970Medicine
    Laboratory of Infectious Diseases, NIAIDPostdoctoral1972-75Virology
    Beth Israel & Children’s Hospitals, Boston, MAPostdoctoral1975-76Infectious Diseases
    Collapse Awards and Honors
    Dartmouth College1965A.B. (cum laude)
    Stanford University1970Alpha Omega Alpha
    Stanford University1970Lowell Rantz Award in Infectious Diseases
    American Medical Association 1976AMA Physicians Recognition Award
    American Medical Association1979AMA Physicians Recognition Award
    American Medical Association1982 AMA Physicians Recognition Award
    1984John Simon Guggenheim Fellowship

    Collapse Research 
    Collapse Research Activities and Funding
    Martin Delaney Collaboratory to Eradicate HIV-1 Infection
    NIH U19AI096113Jul 8, 2011 - Jun 30, 2016
    Role: Co-Investigator
    Gene expression biomarkers of immune recovery in HIV infected patients
    NIH R01AI087164Dec 15, 2009 - Nov 30, 2014
    Role: Principal Investigator
    Targeting regulators of cellular gene transcription to impact HIV latency
    NIH P01AI080193Jun 5, 2009 - Dec 31, 2011
    Role: Principal Investigator
    Determinants of HIV Transmission
    NIH P01AI074621Mar 15, 2008 - Feb 28, 2015
    Role: Co-Investigator
    Meeting Support for HIV Dynamics and Evolution
    NIH R13AI056338Apr 1, 2003 - Jul 31, 2011
    Role: Principal Investigator
    9th Annual International Mtg on HIV Dynamics &Evolution
    NIH R13AI051989Mar 16, 2002 - Mar 15, 2003
    Role: Principal Investigator
    BIOMATHEMATICAL ANALYSIS OF VIRAL DYNAMICS AND EVOLUTION
    NIH R01AI047745Jul 1, 2000 - Dec 31, 2011
    Role: Principal Investigator
    BIOMATHEMATICAL ANALYSIS OF VIRAL DYNAMICS AND EVOLUTION
    NIH R21AI047745Jul 1, 2000 - Jun 30, 2001
    Role: Principal Investigator
    Southern California Primary Infection Program
    NIH U01AI043638Aug 1, 1998 - Jun 30, 2011
    Role: Principal Investigator
    RESISTANCE TO ANTIVIRALS IN HIV INFECTED PATIENTS
    NIH R03TW000767Sep 30, 1996 - Feb 28, 2003
    Role: Principal Investigator
    ANTIVIRAL RESISTANCE IN AIDS
    NIH R03TW000680Sep 1, 1996 - Aug 31, 1999
    Role: Principal Investigator
    Center for AIDS Research
    NIH P30AI036214Apr 1, 1994 - Mar 31, 2023
    Role: Principal Investigator
    HOPE Training Grant
    NIH T32AI007384Aug 1, 1990 - Aug 31, 2026
    Role: Principal Investigator
    RAPID MICROBIAL DIAGNOSIS BY NUCLEIC ACID AMPLIFICATION
    NIH U01AI030457Jul 1, 1990 - Jun 30, 1996
    Role: Principal Investigator
    ANTIVIRAL RESISTANCE IN AIDS
    NIH R37AI029164Sep 30, 1989 - Jun 30, 2006
    Role: Principal Investigator
    MECHANISMS OF RESISTANCE IN CLINICAL ISOLATES OF HIV
    NIH R01AI029164Sep 30, 1989 - Jul 31, 1994
    Role: Principal Investigator
    DEVELOPMENT OF SCREENING TESTS FOR HTLV-III
    NIH/NHLBI N01HB067019Sep 30, 1986 - Sep 29, 1991
    Role: Principal Investigator
    SAN DIEGO AIDS CLINICAL TRIAL UNIT
    NIH U01AI027670Jun 30, 1986 - Dec 31, 2006
    Role: Principal Investigator
    NUCLEIC ACID HYBRIDIZATION TO DETECT AIDS RELATED AGENTS
    NIH R01HL032471Apr 1, 1984 - Mar 31, 1988
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency. Virology. 2022 Jun 04; 573:50-58. Beliakova-Bethell N, Manousopoulou A, Deshmukh S, Mukim A, Richman DD, Garbis SD, Spina CA. PMID: 35714458.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Diagnostic Accuracy of Dried Plasma Spot Specimens for HIV-1 Viral Load Testing: A Systematic Review and Meta-analysis. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):261-273. Fong Y, Markby J, Andreotti M, Beck I, Bourlet T, Brambilla D, Frenkel L, Lira R, Nelson JAE, Pollakis G, Reigadas S, Richman D, Sawadogo S, Waters L, Yang C, Zeh C, Doherty M, Vojnov L. PMID: 34732684; PMCID: PMC8826610.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Is France Once Again Looking for a Scapegoat? Pathog Immun. 2021; 6(2):149-152. Lederman MM, Flier JS, Hale P, Haase AT, Powderly W, Reiss P, Silvestri G, Sekaly RP, Paiardini M, Weissman D, Kuritzkes DR, Calabrese LH, Agre P, Reyes-Teran G, Landay AL, Lewin S, Richman DD, Volberding P, Hunt PW, Schechter M. PMID: 35097250; PMCID: PMC8792773.
      View in: PubMed   Mentions:
    4. Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process. HIV Med. 2022 07; 23(6):639-649. Marques-Gomes J, Salt MJ, Pereira-Neto R, Barteldes FS, Gouveia-Barros V, Carvalho A, d'Arminio-Monforte A, De-la-Torre-Rosas A, Harris A, Esteves C, Maor C, Mora C, Oliveira C, Sousa C, Richman DD, Martinez E, Cota-Medeiros F, Gramacho F, Behrens GMN, Gonçalves G, Farinha H, Nabais I, Vaz-Pinto I, Sierra-Madero J, Sousa-Gago J, Thornhill J, Vera J, Erceg-Tusek M, Tavares M, Vasconcelos M, Fernandes N, Gianotti N, Langebeek N, Anjos P, Couto R, Fernandes R, Rajasuriar R, Serrão R, Watson S, Branco T, Teixeira T, Soriano V. PMID: 34964226.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size. J Infect Dis. 2021 10 13; 224(7):1209-1218. Stone M, Rosenbloom DIS, Bacchetti P, Deng X, Dimapasoc M, Keating S, Bakkour S, Richman DD, Mellors JW, Deeks SG, Lai J, Beg S, Siliciano JD, Pagliuzza A, Chomont N, Lackman-Smith C, Ptak RG, Busch MP. PMID: 32147687; PMCID: PMC8514180.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    6. Immunologic resilience and COVID-19 survival advantage. J Allergy Clin Immunol. 2021 11; 148(5):1176-1191. Lee GC, Restrepo MI, Harper N, Manoharan MS, Smith AM, Meunier JA, Sanchez-Reilly S, Ehsan A, Branum AP, Winter C, Winter L, Jimenez F, Pandranki L, Carrillo A, Perez GL, Anzueto A, Trinh H, Lee M, Hecht JM, Martinez-Vargas C, Sehgal RT, Cadena J, Walter EA, Oakman K, Benavides R, Pugh JA, South Texas Veterans Health Care System COVID-19 Team, Letendre S, Steri M, Orrù V, Fiorillo E, Cucca F, Moreira AG, Zhang N, Leadbetter E, Agan BK, Richman DD, He W, Clark RA, Okulicz JF, Ahuja SK. PMID: 34508765; PMCID: PMC8425719.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Disregarding drug resistance mutations without peril. AIDS. 2021 06 01; 35(7):1135-1136. Richman DD. PMID: 33946088.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. COVID-19 vaccines: implementation, limitations and opportunities. Glob Health Med. 2021 Feb 28; 3(1):1-5. Richman DD. PMID: 33688588; PMCID: PMC7936373.
      View in: PubMed   Mentions: 12  
    9. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2021 02 01; 72(3):495-498. Papasavvas E, Azzoni L, Ross BN, Fair M, Yuan Z, Gyampoh K, Mackiewicz A, Sciorillo AC, Pagliuzza A, Lada SM, Wu G, Goh SL, Bahnck-Teets C, Holder DJ, Zuck PD, Damra M, Lynn KM, Tebas P, Mounzer K, Kostman JR, Abdel-Mohsen M, Richman D, Chomont N, Howell BJ, Montaner LJ. PMID: 33527127; PMCID: PMC7850524.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. Inconsistent reversal of HIV-1 latency ex vivo by antigens of HIV-1, CMV, and other infectious agents. Retrovirology. 2020 11 23; 17(1):36. Vollbrecht T, Angerstein AO, Menke B, Kumar NM, de Oliveira MF, Richman DD, Guatelli JC. PMID: 33228686; PMCID: PMC7684880.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    11. Replicate Aptima Assay for Quantifying Residual Plasma Viremia in Individuals on Antiretroviral Therapy. J Clin Microbiol. 2020 11 18; 58(12). Bakkour S, Deng X, Bacchetti P, Grebe E, Montalvo L, Worlock A, Stone M, Deeks SG, Richman DD, Busch MP. PMID: 32967900; PMCID: PMC7685884.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. Antiviral Drug Discovery To Address the COVID-19 Pandemic. mBio. 2020 09 25; 11(5). Richman DD. PMID: 32978312; PMCID: PMC7520600.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    13. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nat Med. 2020 09; 26(9):1339-1350. Abdel-Mohsen M, Richman D, Siliciano RF, Nussenzweig MC, Howell BJ, Martinez-Picado J, Chomont N, Bar KJ, Yu XG, Lichterfeld M, Alcami J, Hazuda D, Bushman F, Siliciano JD, Betts MR, Spivak AM, Planelles V, Hahn BH, Smith DM, Ho YC, Buzon MJ, Gaebler C, Paiardini M, Li Q, Estes JD, Hope TJ, Kostman J, Mounzer K, Caskey M, Fox L, Frank I, Riley JL, Tebas P, Montaner LJ, BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection. PMID: 32895573; PMCID: PMC7703694.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsPHPublic Health
    14. Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. PLoS Med. 2020 02; 17(2):e1003037. Hermans LE, Carmona S, Nijhuis M, Tempelman HA, Richman DD, Moorhouse M, Grobbee DE, Venter WDF, Wensing AMJ. PMID: 32097428; PMCID: PMC7041795.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. 2019 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2019 09; 27(3):111-121. Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD. PMID: 31634862; PMCID: PMC6892618.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    16. Myroides injenensis Bacteremia and Severe Cellulitis. Open Forum Infect Dis. 2019 Jul; 6(7):ofz282. LaVergne S, Gaufin T, Richman D. PMID: 31334299; PMCID: PMC6634436.
      View in: PubMed   Mentions: 7  
    17. Reply to Ambrosioni et al. Clin Infect Dis. 2019 05 17; 68(11):1977-1978. Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD. PMID: 30520997.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. PLoS Comput Biol. 2019 04; 15(4):e1006849. Rosenbloom DIS, Bacchetti P, Stone M, Deng X, Bosch RJ, Richman DD, Siliciano JD, Mellors JW, Deeks SG, Ptak RG, Hoh R, Keating SM, Dimapasoc M, Massanella M, Lai J, Sobolewski MD, Kulpa DA, Busch MP, Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group. PMID: 30978183; PMCID: PMC6481870.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    19. A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib. BMC Infect Dis. 2019 Mar 27; 19(1):287. Prakash K, Richman D. PMID: 30917797; PMCID: PMC6437885.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV. Retrovirology. 2019 02 15; 16(1):4. Richman DD, Huang K, Lada SM, Sun X, Jain S, Massanella M, Menke B. PMID: 30770748; PMCID: PMC6377736.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    21. Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation. J Biol Chem. 2019 04 05; 294(14):5576-5589. Beliakova-Bethell N, Mukim A, White CH, Deshmukh S, Abewe H, Richman DD, Spina CA. PMID: 30745362; PMCID: PMC6462528.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    22. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel. Clin Infect Dis. 2019 01 07; 68(2):177-187. Günthard HF, Calvez V, Paredes R, Pillay D, Shafer RW, Wensing AM, Jacobsen DM, Richman DD. PMID: 30052811; PMCID: PMC6321850.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    23. Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol. 2018 12; 56(12). Lada SM, Huang K, VanBelzen DJ, Montaner LJ, O'Doherty U, Richman DD. PMID: 30232127; PMCID: PMC6258838.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    24. Improved assays to measure and characterize the inducible HIV reservoir. EBioMedicine. 2018 Oct; 36:113-121. Massanella M, Yek C, Lada SM, Nakazawa M, Shefa N, Huang K, Richman DD. PMID: 30316868; PMCID: PMC6197429.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    25. Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV. AIDS. 2018 08 24; 32(13):1763-1772. Papasavvas E, Lada SM, Joseph J, Yin X, Liu Q, Azzoni L, Mounzer K, Kostman JR, Richman D, Montaner LJ. PMID: 30045057; PMCID: PMC6289896.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    26. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Sci Immunol. 2018 08 17; 3(26). Lofano G, Gorman MJ, Yousif AS, Yu WH, Fox JM, Dugast AS, Ackerman ME, Suscovich TJ, Weiner J, Barouch D, Streeck H, Little S, Smith D, Richman D, Lauffenburger D, Walker BD, Diamond MS, Alter G. PMID: 30120121; PMCID: PMC6298214.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    27. Transplantation of CCR5∆32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection. Open Forum Infect Dis. 2018 May; 5(5):ofy090. Rothenberger M, Wagner JE, Haase A, Richman D, Grzywacz B, Strain M, Lada S, Estes J, Fletcher CV, Podany AT, Anderson J, Schmidt T, Wietgrefe S, Schacker T, Verneris MR. PMID: 29868623; PMCID: PMC5965100.
      View in: PubMed   Mentions: 6  
    28. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med. 2018 04 18; 10(437). Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ. PMID: 29669853; PMCID: PMC6282755.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    29. Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment. Front Immunol. 2018; 9:603. White CH, Beliakova-Bethell N, Lada SM, Breen MS, Hurst TP, Spina CA, Richman DD, Frater J, Magiorkinis G, Woelk CH. PMID: 29706951; PMCID: PMC5906534.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    30. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors. AIDS. 2018 02 20; 32(4):443-450. Sadanand S, Das J, Chung AW, Schoen MK, Lane S, Suscovich TJ, Streeck H, Smith DM, Little SJ, Lauffenburger DA, Richman DD, Alter G. PMID: 29239894; PMCID: PMC5983383.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    31. Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy. Open Forum Infect Dis. 2018 Feb; 5(2):ofy032. Ruggiero A, Cozzi-Lepri A, Beloukas A, Richman D, Khoo S, Phillips A, Geretti AM, ERAS Study Group. PMID: 29507867; PMCID: PMC5825920.
      View in: PubMed   Mentions: 8  
    32. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol. 2018 02 01; 92(3). Chaillon A, Gianella S, Lada SM, Perez-Santiago J, Jordan P, Ignacio C, Karris M, Richman DD, Mehta SR, Little SJ, Wertheim JO, Smith DM. PMID: 29142136; PMCID: PMC5774877.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    33. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122; PMCID: PMC5677050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study. PLoS Med. 2017 Nov; 14(11):e1002461. Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, Chun TW, Rhame F, Baker JV, Busch MP, Chomont N, Dean PG, Fromentin R, Haase AT, Hampton D, Keating SM, Lada SM, Lee TH, Natesampillai S, Richman DD, Schacker TW, Wietgrefe S, Yu XG, Yao JD, Zeuli J, Lichterfeld M, Badley AD. PMID: 29182633; PMCID: PMC5705162.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    35. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018 02; 18(2):188-197. Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WDF, Wensing AMJ. PMID: 29158101.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    36. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956; PMCID: PMC5675377.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCellsPHPublic Health
    37. Mark Wainberg. Curr Opin HIV AIDS. 2017 09; 12(5):423-424. Richman DD, Gallo RC. PMID: 28771448.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response. J Virol. 2017 09 01; 91(17). Wagner GA, Landais E, Caballero G, Phung P, Kosakovsky Pond SL, Poignard P, Richman DD, Little SJ, Smith DM. PMID: 28615205; PMCID: PMC5553187.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    39. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology. 2017 08; 508:127-133. Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman DD, Spina CA. PMID: 28527342; PMCID: PMC5654527.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    40. Evaluation of the Aptima HIV-1 Quant Dx Assay for HIV-1 RNA Quantitation in Different Biological Specimen Types. J Clin Microbiol. 2017 08; 55(8):2544-2553. Yek C, Massanella M, Peling T, Lednovich K, Nair SV, Worlock A, Vargas M, Gianella S, Ellis RJ, Strain MC, Busch MP, Nugent CT, Richman DD. PMID: 28592548; PMCID: PMC5527433.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    41. Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles. AIDS. 2017 05 15; 31(8):1149-1158. Vesa J, Chaillon A, Wagner GA, Anderson CM, Richman DD, Smith DM, Little SJ. PMID: 28244954; PMCID: PMC5559224.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1. J Infect Dis. 2017 05 15; 215(10):1506-1513. Choi JY, Pond SLK, Anderson CM, Richman DD, Smith DM. PMID: 28419276; PMCID: PMC6281333.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    43. HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy. Nat Med. 2017 May; 23(5):638-643. Honeycutt JB, Thayer WO, Baker CE, Ribeiro RM, Lada SM, Cao Y, Cleary RA, Hudgens MG, Richman DD, Garcia JV. PMID: 28414330; PMCID: PMC5419854.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansAnimalsCells
    44. HIV: Finding latent needles in a haystack. Nature. 2017 03 23; 543(7646):499-500. Richman DD. PMID: 28297707.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. 2017 Update of the Drug Resistance Mutations in HIV-1. Top Antivir Med. 2016 12; 24(4):132-133. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. PMID: 28208121; PMCID: PMC5677049.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCells
    46. Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model. PLoS Pathog. 2016 Nov; 12(11):e1006026. White CH, Moesker B, Beliakova-Bethell N, Martins LJ, Spina CA, Margolis DM, Richman DD, Planelles V, Bosque A, Woelk CH. PMID: 27898737; PMCID: PMC5127598.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    47. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 11 13; 30(17):2591-2597. Wagner GA, Chaillon A, Liu S, Franklin DR, Caballero G, Kosakovsky Pond SL, Vaida F, Heaton RK, Letendre SL, Grant I, Richman DD, Smith DM. PMID: 27536983; PMCID: PMC5083206.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    48. A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics. Medicine (Baltimore). 2016 Nov; 95(44):e5315. Karris MY, Umlauf A, Vaida F, Richman D, Little S, Smith D. PMID: 27858912; PMCID: PMC5591160.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    49. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med. 2016 09; 22(9):1043-9. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA, Lai J, Strain MC, Lada SM, Hoh R, Ho YC, Richman DD, Deeks SG, Siliciano JD, Siliciano RF. PMID: 27500724; PMCID: PMC5014606.
      View in: PubMed   Mentions: 351     Fields:    Translation:HumansCells
    50. Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy. PLoS One. 2016; 11(8):e0160192. Lee SA, Bacchetti P, Chomont N, Fromentin R, Lewin SR, O'Doherty U, Palmer S, Richman DD, Siliciano JD, Yukl SA, Deeks SG, Burbelo PD. PMID: 27483366; PMCID: PMC4970722.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    51. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 08; 22(8):839-50. Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F, International AIDS Society Towards a Cure Working Group, Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J. PMID: 27400264; PMCID: PMC5322797.
      View in: PubMed   Mentions: 244     Fields:    Translation:Humans
    52. Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples. Virus Evol. 2016 Jul; 2(2):vew018. Laird Smith M, Murrell B, Eren K, Ignacio C, Landais E, Weaver S, Phung P, Ludka C, Hepler L, Caballero G, Pollner T, Guo Y, Richman D, IAVI Protocol C Investigators & The IAVI African HIV Research Network, Poignard P, Paxinos EE, Kosakovsky Pond SL, Smith DM. PMID: 29492273; PMCID: PMC5822884.
      View in: PubMed   Mentions: 17  
    53. Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM. Virus Evol. 2016 Jan; 2(1):vew012. Chaillon A, Gianella S, Little SJ, Caballero G, Barin F, Kosakovsky Pond S, Richman DD, Smith DM, Mehta SR. PMID: 30186625; PMCID: PMC6118227.
      View in: PubMed   Mentions: 7  
    54. Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California. Clin Infect Dis. 2016 07 01; 63(1):101-107. Mehta SR, Murrell B, Anderson CM, Kosakovsky Pond SL, Wertheim JO, Young JA, Freitas L, Richman DD, Mathews WC, Scheffler K, Little SJ, Smith DM. PMID: 27174704; PMCID: PMC4901863.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    55. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection. J Virol. 2016 Apr; 90(8):3944-3952. Gianella S, Anderson CM, Var SR, Oliveira MF, Lada SM, Vargas MV, Massanella M, Little SJ, Richman DD, Strain MC, Pérez-Santiago J, Smith DM. PMID: 26842469; PMCID: PMC4810527.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    56. Editorial Commentary: HIV Is Putting Up Less Resistance. Clin Infect Dis. 2016 05 15; 62(10):1318-9. Richman DD. PMID: 26962077.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    57. Measuring the latent reservoir in vivo. J Clin Invest. 2016 Feb; 126(2):464-72. Massanella M, Richman DD. PMID: 26829625; PMCID: PMC4731179.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    58. Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013. J Acquir Immune Defic Syndr. 2016 Feb 01; 71(2):228-36. Panichsillapakit T, Smith DM, Wertheim JO, Richman DD, Little SJ, Mehta SR. PMID: 26413846; PMCID: PMC4712087.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    59. Colorectal Disorders in Acute Human Immunodeficiency Virus Infection: A Case Series. Open Forum Infect Dis. 2016 Jan; 3(1):ofw014. Panichsillapakit T, Patel D, Santangelo J, Richman DD, Little SJ, Smith DM. PMID: 26925432; PMCID: PMC4766383.
      View in: PubMed   Mentions:
    60. HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLoS One. 2015; 10(12):e0145772. Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, Van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, De Oliveira T, Wensing AM, Gallant JE, Wainberg MA, Richman DD, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW. PMID: 26717411; PMCID: PMC4696791.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    61. HIV: Cure by killing. Nature. 2015 Dec 10; 528(7581):198-9. Richman DD. PMID: 26633623.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    62. No evidence of posttreatment control after early initiation of antiretroviral therapy. AIDS. 2015 Oct 23; 29(16):2093-7. Gianella S, Anderson CM, Richman DD, Smith DM, Little SJ. PMID: 26544575; PMCID: PMC4638137.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    63. 2015 Update of the Drug Resistance Mutations in HIV-1. Top Antivir Med. 2015 Oct-Nov; 23(4):132-41. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. PMID: 26713503; PMCID: PMC6148920.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    64. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency. Antiviral Res. 2015 Nov; 123:78-85. White CH, Johnston HE, Moesker B, Manousopoulou A, Margolis DM, Richman DD, Spina CA, Garbis SD, Woelk CH, Beliakova-Bethell N. PMID: 26343910; PMCID: PMC5606336.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    65. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015 Aug 24; 5:13179. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. PMID: 26299251; PMCID: PMC4547398.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    66. During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ. EBioMedicine. 2015 Sep; 2(9):1153-9. Ruggiero A, De Spiegelaere W, Cozzi-Lepri A, Kiselinova M, Pollakis G, Beloukas A, Vandekerckhove L, Strain M, Richman D, Phillips A, Geretti AM, ERAS Study Group. PMID: 26498496; PMCID: PMC4588402.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    67. Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain. J Virus Erad. 2015 Jul 01; 1(3):211-20. Rokx C, Richman DD, Müller-Trutwin M, Silvestri G, Lunzen J, Khoo S, Lichterfeld M, Altfeld M, Perno CF, Hunt PW, Mallon P, Rockstroh JK, Pozniak AL, Clotet B, Boucher CA. PMID: 27482415; PMCID: PMC4946744.
      View in: PubMed   Mentions:
    68. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals. EBioMedicine. 2015 Aug; 2(8):874-83. Procopio FA, Fromentin R, Kulpa DA, Brehm JH, Bebin AG, Strain MC, Richman DD, O'Doherty U, Palmer S, Hecht FM, Hoh R, Barnard RJ, Miller MD, Hazuda DJ, Deeks SG, Sékaly RP, Chomont N. PMID: 26425694; PMCID: PMC4563128.
      View in: PubMed   Mentions: 152     Fields:    Translation:HumansCells
    69. Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs. Bio Protoc. 2015 Jun 05; 5(11). Massanella M, Gianella S, Lada SM, Richman DD, Strain MC. PMID: 27478862; PMCID: PMC4962884.
      View in: PubMed   Mentions: 20  
    70. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. AIDS. 2015 Feb 20; 29(4):411-20. Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK. PMID: 25602681; PMCID: PMC4385712.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    71. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med. 2015 Jan; 175(1):88-99. Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD, Little SJ, Clark RA, He W, Ahuja SK. PMID: 25419650; PMCID: PMC4286496.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    72. Preface. Curr Top Microbiol Immunol. 2015; 389:v-vii. Torbett BE, Goodsell DS, Richman DD. PMID: 26086053.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    73. Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals. PLoS One. 2014; 9(12):e114142. Massanella M, Ouchi D, Marfil S, Llibre JM, Puertas MC, Buzón MJ, Richman DD, Orna E, Stevenson M, Gatell JM, Domingo P, Negredo E, Martinez-Picado J, Clotet B, Blanco J. PMID: 25462535; PMCID: PMC4252101.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    74. Influence of age at virologic control on peripheral blood human immunodeficiency virus reservoir size and serostatus in perinatally infected adolescents. JAMA Pediatr. 2014 Dec; 168(12):1138-46. Persaud D, Patel K, Karalius B, Rainwater-Lovett K, Ziemniak C, Ellis A, Chen YH, Richman D, Siberry GK, Van Dyke RB, Burchett S, Seage GR, Luzuriaga K, Pediatric HIV/AIDS Cohort Study. PMID: 25286283; PMCID: PMC4324476.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCellsPHPublic Health
    75. HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing. Virology. 2015 Jan 01; 474:34-40. Carter CC, Wagner GA, Hightower GK, Caballero G, Phung P, Richman DD, Pond SL, Smith DM. PMID: 25463602; PMCID: PMC4259848.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    76. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells. PLoS One. 2014; 9(10):e110731. Cockerham LR, Siliciano JD, Sinclair E, O'Doherty U, Palmer S, Yukl SA, Strain MC, Chomont N, Hecht FM, Siliciano RF, Richman DD, Deeks SG. PMID: 25340755; PMCID: PMC4207702.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    77. IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform. PLoS Comput Biol. 2014 Sep; 10(9):e1003842. Hepler NL, Scheffler K, Weaver S, Murrell B, Richman DD, Burton DR, Poignard P, Smith DM, Kosakovsky Pond SL. PMID: 25254639; PMCID: PMC4177671.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    78. Editorial overview: antivirals and resistance: advances and challenges ahead. Curr Opin Virol. 2014 Oct; 8:iv-vii. Menéndez-Arias L, Richman DD. PMID: 25155454; PMCID: PMC7129102.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    79. Joep MA Lange. Antivir Ther. 2014; 19(4):325-6. Richman DD. PMID: 25118622.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 2014 Jul; 10(7):e1004281. Kim EY, Lorenzo-Redondo R, Little SJ, Chung YS, Phalora PK, Maljkovic Berry I, Archer J, Penugonda S, Fischer W, Richman DD, Bhattacharya T, Malim MH, Wolinsky SM. PMID: 25080100; PMCID: PMC4117599.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    81. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy. J Infect Dis. 2014 Dec 01; 210(11):1838-43. Wang C, Abdel-Mohsen M, Strain MC, Lada SM, Yukl S, Cockerham LR, Pilcher CD, Hecht FM, Sinclair E, Liegler T, Richman DD, Deeks SG, Pillai SK. PMID: 24935955; PMCID: PMC4271057.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    82. 2014 Update of the drug resistance mutations in HIV-1. Top Antivir Med. 2014 Jun-Jul; 22(3):642-50. Wensing AM, Calvez V, Günthard HF, Johnson VA, Paredes R, Pillay D, Shafer RW, Richman DD. PMID: 25101529; PMCID: PMC4392881.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    83. HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis. 2014 Nov 15; 210(10):1529-38. Luzuriaga K, Tabak B, Garber M, Chen YH, Ziemniak C, McManus MM, Murray D, Strain MC, Richman DD, Chun TW, Cunningham CK, Persaud D. PMID: 24850788; PMCID: PMC4215073.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsPHPublic Health
    84. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol. 2014 Jul; 88(14):7818-27. Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM, California Collaborative Treatment Group 592 Team. PMID: 24789781; PMCID: PMC4097769.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    85. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection. AIDS. 2014 Mar 27; 28(6):841-9. Karris MY, Kao YT, Patel D, Dawson M, Woods SP, Vaida F, Spina C, Richman D, Little S, Smith DM. PMID: 24401640; PMCID: PMC4049563.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    86. HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat. J Infect Dis. 2014 Sep 01; 210(5):728-35. Archin NM, Bateson R, Tripathy MK, Crooks AM, Yang KH, Dahl NP, Kearney MF, Anderson EM, Coffin JM, Strain MC, Richman DD, Robertson KR, Kashuba AD, Bosch RJ, Hazuda DJ, Kuruc JD, Eron JJ, Margolis DM. PMID: 24620025; PMCID: PMC4148603.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansCells
    87. Editorial Commentary: Extending HIV drug resistance testing to low levels of plasma viremia. Clin Infect Dis. 2014 Apr; 58(8):1174-5. Richman DD. PMID: 24429434.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    88. HIV migration between blood and cerebrospinal fluid or semen over time. J Infect Dis. 2014 May 15; 209(10):1642-52. Chaillon A, Gianella S, Wertheim JO, Richman DD, Mehta SR, Smith DM. PMID: 24302756; PMCID: PMC3997580.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    89. Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States. J Infect Dis. 2014 Apr 01; 209(7):1032-8. Wagner GA, Pacold ME, Kosakovsky Pond SL, Caballero G, Chaillon A, Rudolph AE, Morris SR, Little SJ, Richman DD, Smith DM. PMID: 24273040; PMCID: PMC3952674.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    90. Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation. Clin Vaccine Immunol. 2014 Jan; 21(1):46-50. Tatro ET, Purnajo I, Richman DD, Smith DM, Gianella S. PMID: 24173027; PMCID: PMC3910916.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    91. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013 Nov 07; 369(19):1828-35. Persaud D, Gay H, Ziemniak C, Chen YH, Piatak M, Chun TW, Strain M, Richman D, Luzuriaga K. PMID: 24152233; PMCID: PMC3954754.
      View in: PubMed   Mentions: 293     Fields:    Translation:HumansCells
    92. The global transmission network of HIV-1. J Infect Dis. 2014 Jan 15; 209(2):304-13. Wertheim JO, Leigh Brown AJ, Hepler NL, Mehta SR, Richman DD, Smith DM, Kosakovsky Pond SL. PMID: 24151309; PMCID: PMC3873788.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCellsPHPublic Health
    93. Novel codon insert in HIV type 1 clade B reverse transcriptase associated with low-level viremia during antiretroviral therapy. AIDS Res Hum Retroviruses. 2014 Feb; 30(2):165-9. Chaillon A, Gianella S, Vazquez H, Ignacio C, Zweig AC, Richman DD, Smith DM. PMID: 24020934; PMCID: PMC3910474.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    94. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection. J Virol. 2013 Dec; 87(23):12737-44. Chaillon A, Wagner GA, Hepler NL, Little SJ, Kosakovsky Pond SL, Caballero G, Pacold ME, Phung P, Wrin T, Richman DD, Wertheim JO, Smith DM. PMID: 24049166; PMCID: PMC3838120.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    95. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. PLoS One. 2013; 8(9):e73956. DeBoever C, Reid EG, Smith EN, Wang X, Dumaop W, Harismendy O, Carson D, Richman D, Masliah E, Frazer KA. PMID: 24023918; PMCID: PMC3762708.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    96. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013 Nov 01; 208(9):1436-42. Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman DD, Deeks SG. PMID: 23975885; PMCID: PMC3789577.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    97. Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis. 2014 Feb 01; 209(3):452-6. Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman DD, Little SJ, Smith DM. PMID: 23964106; PMCID: PMC3883163.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    98. Differential gene expression in HIV-infected individuals following ART. Antiviral Res. 2013 Nov; 100(2):420-8. Massanella M, Singhania A, Beliakova-Bethell N, Pier R, Lada SM, White CH, Pérez-Santiago J, Blanco J, Richman DD, Little SJ, Woelk CH. PMID: 23933117; PMCID: PMC3899918.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    99. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS. 2013 Jul 31; 27(12):1921-31. Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman DD, Smith DM. PMID: 24180001; PMCID: PMC3816380.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    100. HIV-1 clade B pol evolution following primary infection. PLoS One. 2013; 8(6):e68188. Hightower GK, May SJ, Pérez-Santiago J, Pacold ME, Wagner GA, Little SJ, Richman DD, Mehta SR, Smith DM, Pond SL. PMID: 23840830; PMCID: PMC3695957.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    101. A synthetic bivalent ligand of CXCR4 inhibits HIV infection. Biochem Biophys Res Commun. 2013 Jun 14; 435(4):646-50. Xu Y, Duggineni S, Espitia S, Richman DD, An J, Huang Z. PMID: 23688427; PMCID: PMC3752463.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    102. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. PMID: 23671416; PMCID: PMC3649997.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCellsCTClinical Trials
    103. How to best measure HIV reservoirs? Curr Opin HIV AIDS. 2013 May; 8(3):170-5. Rouzioux C, Richman D. PMID: 23564004; PMCID: PMC3763804.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    104. Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection. J Infect Dis. 2013 Jul 15; 208(2):271-4. Wagner GA, Pacold ME, Vigil E, Caballero G, Morris SR, Kosakovsky Pond SL, Little SJ, Richman DD, Gianella S, Smith DM. PMID: 23599311; PMCID: PMC3685231.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    105. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013 Aug; 57(3):441-7. Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR, CCTG 592 Team. PMID: 23595831; PMCID: PMC3703105.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    106. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One. 2013; 8(4):e55943. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina CA, Woelk CH, Richman DD. PMID: 23573183; PMCID: PMC3616050.
      View in: PubMed   Mentions: 235     Fields:    Translation:HumansCells
    107. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013 Jun 15; 381(9883):2109-17. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman DD, Sekaly RP. PMID: 23541541; PMCID: PMC3815451.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansCells
    108. New assays for monitoring residual HIV burden in effectively treated individuals. Curr Opin HIV AIDS. 2013 Mar; 8(2):106-10. Strain MC, Richman DD. PMID: 23314907; PMCID: PMC3754420.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    109. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013 Feb; 9(2):e1003174. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O'Doherty U, Palmer S, Deeks SG, Siliciano JD. PMID: 23459007; PMCID: PMC3573107.
      View in: PubMed   Mentions: 342     Fields:    Translation:HumansCells
    110. Update of the drug resistance mutations in HIV-1: March 2013. Top Antivir Med. 2013 Feb-Mar; 21(1):6-14. Johnson VA, Calvez V, Gunthard HF, Paredes R, Pillay D, Shafer RW, Wensing AM, Richman DD. PMID: 23596273; PMCID: PMC6148891.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCells
    111. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013 Jan 17; 368(3):218-30. Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK. PMID: 23323898; PMCID: PMC3657555.
      View in: PubMed   Mentions: 193     Fields:    Translation:HumansCells
    112. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells. AIDS. 2013 Jan 02; 27(1):29-37. Beliakova-Bethell N, Zhang JX, Singhania A, Lee V, Terry VH, Richman DD, Spina CA, Woelk CH. PMID: 23221426; PMCID: PMC3752851.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    113. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. AIDS. 2013 Jan 02; 27(1):39-47. Gianella S, Morris SR, Anderson C, Spina CA, Vargas MV, Young JA, Richman DD, Little SJ, Smith DM. PMID: 22739399; PMCID: PMC3769229.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    114. HIV downregulates interferon-stimulated genes in primary macrophages. J Interferon Cytokine Res. 2013 Feb; 33(2):90-5. Wie SH, Du P, Luong TQ, Rought SE, Beliakova-Bethell N, Lozach J, Corbeil J, Kornbluth RS, Richman DD, Woelk CH. PMID: 23276142; PMCID: PMC3573720.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    115. Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. J Infect Dis. 2013 Mar 15; 207(6):898-902. Gianella S, Anderson CM, Vargas MV, Richman DD, Little SJ, Morris SR, Smith DM. PMID: 23275608; PMCID: PMC3571441.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    116. Role of seminal shedding of herpesviruses in HIV Type 1 Transmission. J Infect Dis. 2013 Jan 15; 207(2):257-61. Gianella S, Morris SR, Vargas MV, Young JA, Callahan B, Richman DD, Little SJ, Smith DM. PMID: 23148284; PMCID: PMC3532824.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    117. Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. J Med Virol. 2012 Nov; 84(11):1703-9. Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. PMID: 22997072; PMCID: PMC3472447.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    118. Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther. 2013; 18(1):115-23. Stadeli KM, Richman DD. PMID: 23052978; PMCID: PMC4295493.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    119. Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells. Virology. 2012 Dec 05; 434(1):2-4. Gianella S, Mehta SR, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. PMID: 23040890; PMCID: PMC3485073.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    120. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 Nov 25; 433(2):498-505. Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM, CHARTER Study Group. PMID: 22999095; PMCID: PMC3466337.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    121. Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells. J Mol Med (Berl). 2013 Feb; 91(2):261-70. Soto PC, Karris MY, Spina CA, Richman DD, Varki A. PMID: 22945238; PMCID: PMC3558668.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    122. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. PMID: 22820792.
      View in: PubMed   Mentions: 353     Fields:    Translation:Humans
    123. Antiretroviral drug resistance in resource-limited settings. Lancet. 2012 Oct 06; 380(9849):1210-1. Richman DD. PMID: 22828483.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    124. A combined screening platform for HIV treatment failure and resistance. PLoS One. 2012; 7(4):e35401. Tilghman MW, May S, Pérez-Santiago J, Ignacio CC, Little SJ, Richman DD, Smith DM. PMID: 22563383; PMCID: PMC3338506.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    125. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 Apr; 18(2):81-90. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM, Charter Group. PMID: 22528397; PMCID: PMC3572198.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    126. Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. J Infect Dis. 2012 May 15; 205(10):1529-33. Mehta SR, Kosakovsky Pond SL, Young JA, Richman D, Little S, Smith DM. PMID: 22448013; PMCID: PMC3415817.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    127. Probing chelation motifs in HIV integrase inhibitors. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2251-6. Agrawal A, DeSoto J, Fullagar JL, Maddali K, Rostami S, Richman DD, Pommier Y, Cohen SM. PMID: 22308350; PMCID: PMC3289312.
      View in: PubMed   Mentions: 19     Fields:    
    128. Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men. AIDS. 2012 Jan 14; 26(2):157-65. Pacold ME, Pond SL, Wagner GA, Delport W, Bourque DL, Richman DD, Little SJ, Smith DM. PMID: 22045341; PMCID: PMC3807679.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    129. Associations between virologic and immunologic dynamics in blood and in the male genital tract. J Virol. 2012 Feb; 86(3):1307-15. Gianella S, Strain MC, Rought SE, Vargas MV, Little SJ, Richman DD, Spina CA, Smith DM. PMID: 22114342; PMCID: PMC3264378.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    130. 2011 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2011 Nov; 19(4):156-64. Johnson VA, Calvez V, Günthard HF, Paredes R, Pillay D, Shafer R, Wensing AM, Richman DD. PMID: 22156218; PMCID: PMC6148877.
      View in: PubMed   Mentions: 144     Fields:    Translation:HumansCells
    131. The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of Mycobacteria. Lab Med. 2011 Oct 01; 42(10):612-617. Jeong J, Kim SR, Lee SH, Lim JH, Choi JI, Park JS, Chang CL, Choi JY, Richman DD, Smith DM. PMID: 24443588; PMCID: PMC3892985.
      View in: PubMed   Mentions: 9     Fields:    
    132. Inhibition of HIV-1 by octadecyloxyethyl esters of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] nucleosides and evaluation of their mechanism of action. Antimicrob Agents Chemother. 2011 Nov; 55(11):5063-72. Magee WC, Valiaeva N, Beadle JR, Richman DD, Hostetler KY, Evans DH. PMID: 21896914; PMCID: PMC3195056.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    133. Upregulation of BST-2/Tetherin by HIV infection in vivo. J Virol. 2011 Oct; 85(20):10659-68. Homann S, Smith D, Little S, Richman D, Guatelli J. PMID: 21849457; PMCID: PMC3187519.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    134. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol. 2011 Aug; 85(16):8359-67. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. PMID: 21632754; PMCID: PMC3147985.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    135. Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico. J Acquir Immune Defic Syndr. 2011 Mar 01; 56(3):e70-4. Tilghman MW, Guerena DD, Licea A, Pérez-Santiago J, Richman DD, May S, Smith DM. PMID: 21124228; PMCID: PMC3039117.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    136. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011 Feb 15; 203(4):442-51. Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E. PMID: 21245157; PMCID: PMC3071223.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCellsPHPublic Health
    137. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies. Antivir Ther. 2011; 16(2):263-86. Mascolini M, Mellors JW, Richman DD, Boucher CA, Larder BA. PMID: 21447877.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    138. Introduction: challenges to finding a cure for HIV infection. Curr Opin HIV AIDS. 2011 Jan; 6(1):1-3. Richman DD. PMID: 21242886; PMCID: PMC3077900.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    139. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med. 2010 Dec; 18(5):156-63. Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 21245516.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    140. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, et al. PMID: 21051598; PMCID: PMC3235490.
      View in: PubMed   Mentions: 654     Fields:    Translation:HumansCells
    141. Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses. 2010 Dec; 26(12):1291-8. Pacold M, Smith D, Little S, Cheng PM, Jordan P, Ignacio C, Richman D, Pond SK. PMID: 20954840; PMCID: PMC3011997.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    142. Minority variants of drug-resistant HIV. J Infect Dis. 2010 Sep 01; 202(5):657-66. Gianella S, Richman DD. PMID: 20649427; PMCID: PMC2916955.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    143. Response to Comment on "The Origins of Sexually Transmitted HIV Among Men Who Have Sex with Men" Sci Transl Med. 2010 Sep; 2(50):501r1. Smith D, Delport W, Butler D, Little S, Richman D, Pond SK. PMID: 21532938; PMCID: PMC3083242.
      View in: PubMed   Mentions: 6     Fields:    
    144. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT, International AIDS Society-USA. PMID: 20639566.
      View in: PubMed   Mentions: 328     Fields:    Translation:HumansCells
    145. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med. 2010 Jun 15; 152(12):778-85. Morris SR, Little SJ, Cunningham T, Garfein RS, Richman DD, Smith DM. PMID: 20547906; PMCID: PMC2922925.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansPHPublic Health
    146. Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):609-11. Manosuthi W, Butler DM, Chantratita W, Sukasem C, Richman DD, Smith DM. PMID: 20507208; PMCID: PMC2982719.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    147. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J Infect Dis. 2010 May 01; 201(9):1298-302. Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH, Schafer K, Richman D, Little S. PMID: 20235838; PMCID: PMC2851487.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    148. Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 2010 Mar 13; 24(5):707-16. Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R, California Collaborative Treatment Group. PMID: 20087154.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    149. The origins of sexually transmitted HIV among men who have sex with men. Sci Transl Med. 2010 Feb 10; 2(18):18re1. Butler DM, Delport W, Kosakovsky Pond SL, Lakdawala MK, Cheng PM, Little SJ, Richman DD, Smith DM. PMID: 20371483; PMCID: PMC2945226.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    150. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS. 2010 Jan 28; 24(3):411-6. Manosuthi W, Butler DM, Pérez-Santiago J, Poon AF, Pillai SK, Mehta SR, Pacold ME, Richman DD, Pond SK, Smith DM. PMID: 20009919; PMCID: PMC2913588.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    151. Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery. AIDS. 2010 Jan 16; 24(2):217-22. Woelk CH, Beliakova-Bethell N, Goicoechea M, Zhao Y, Du P, Rought SE, Lozach J, Pérez-Santiago J, Richman DD, Smith DM, Little SJ. PMID: 19952713; PMCID: PMC2915828.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    152. Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1. Mol Biol Evol. 2010 Apr; 27(4):819-32. Poon AF, Swenson LC, Dong WW, Deng W, Kosakovsky Pond SL, Brumme ZL, Mullins JI, Richman DD, Harrigan PR, Frost SD. PMID: 19955476; PMCID: PMC2877536.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    153. Update of the drug resistance mutations in HIV-1: December 2009. Top HIV Med. 2009 Dec; 17(5):138-45. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 20068260.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    154. Interlaboratory measurement differences in intracellular carbovir triphosphate concentrations in HIV-infected patients: sources of variability in processing, shipping, and quantitation. J Clin Pharmacol. 2010 Aug; 50(8):968-74. Goicoechea M, Jain S, Bi L, Sun S, Smith G, Ha B, Richman D, Louie S, Haubrich R, California Collaborative Treatment Group. PMID: 19952374.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    155. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS. 2009 Oct 23; 23(16):2151-8. Smith DM, May SJ, Pérez-Santiago J, Strain MC, Ignacio CC, Haubrich RH, Richman DD, Benson CA, Little SJ. PMID: 19730348; PMCID: PMC2915784.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    156. Poor agreement between 2 assays for measuring low levels of HIV-1 viral load. Clin Infect Dis. 2009 Oct 15; 49(8):1283-4. Montaner JS, Richman DD, Hammer SM, International AIDS Society-USA Antiretroviral Guidelines Panel. PMID: 19780662.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    157. Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance. Virology. 2009 Nov 25; 394(2):243-8. Hightower GK, Letendre SL, Cherner M, Gibson SA, Ellis RJ, Wolfson TJ, Gamst AC, Ignacio CC, Heaton RK, Grant I, Richman DD, Smith DM, HNRC Group. PMID: 19762060; PMCID: PMC3046809.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    158. The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool. J Virol Methods. 2009 Dec; 162(1-2):280-3. Butler DM, Pacold ME, Jordan PS, Richman DD, Smith DM. PMID: 19698751; PMCID: PMC2761514.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    159. A novel codon insert in protease of clade B HIV type 1. AIDS Res Hum Retroviruses. 2009 May; 25(5):547-50. Jordan PS, Poon A, Eron J, Squires K, Ignacio C, Richman DD, Smith DM. PMID: 19397401; PMCID: PMC2749665.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    160. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrob Agents Chemother. 2009 Jun; 53(6):2335-41. Eron JJ, Park JG, Haubrich R, Aweeka F, Bastow B, Pakes GE, Yu S, Wu H, Richman DD, ACTG5126 Study Team. PMID: 19307363; PMCID: PMC2687257.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    161. The challenge of finding a cure for HIV infection. Science. 2009 Mar 06; 323(5919):1304-7. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. PMID: 19265012.
      View in: PubMed   Mentions: 449     Fields:    Translation:HumansAnimalsCells
    162. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. PMID: 19268337; PMCID: PMC4474533.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    163. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS. 2009 Jan 14; 23(2):225-32. Smith DM, May SJ, Tweeten S, Drumright L, Pacold ME, Kosakovsky Pond SL, Pesano RL, Lie YS, Richman DD, Frost SD, Woelk CH, Little SJ. PMID: 19098493; PMCID: PMC2644048.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCellsPHPublic Health
    164. Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop. Antivir Ther. 2009; 14(7):1015-37. Mascolini M, Boucher CA, Mellors JW, Larder BA, Richman DD. PMID: 19918107.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    165. Evaluation of a highly sensitive qualitative human immunodeficiency virus type 1 (HIV-1) RNA assay for detection of HIV-1 suppression. J Clin Microbiol. 2009 Mar; 47(3):833-6. Nugent CT, Nodelman V, Giachetti C, Richman DD, Looney DJ. PMID: 19116355; PMCID: PMC2650919.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    166. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 2009 Mar 01; 385(1):204-8. Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ, HNRC Group. PMID: 19100592; PMCID: PMC2794037.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    167. Update of the Drug Resistance Mutations in HIV-1. Top HIV Med. 2008 Dec; 16(5):138-45. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 19106428.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    168. Optimizing peptide matrices for identifying T-cell antigens. Cytometry A. 2008 Nov; 73(11):1071-8. Precopio ML, Butterfield TR, Casazza JP, Little SJ, Richman DD, Koup RA, Roederer M. PMID: 18781655; PMCID: PMC2586828.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    169. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol. 2008 Dec; 82(23):11651-68. Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, Davis KL, Decker JM, Wycuff D, Harris L, Hawkins N, Wood B, Nathe C, Richman D, Tomaras GD, Bibollet-Ruche F, Robinson JE, Morris L, Shaw GM, Montefiori DC, Mascola JR. PMID: 18815292; PMCID: PMC2583680.
      View in: PubMed   Mentions: 245     Fields:    Translation:HumansAnimalsCells
    170. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS. 2008 Aug 20; 22(13):1667-71. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, Richman DD, Little SJ. PMID: 18670228; PMCID: PMC2653089.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsPHPublic Health
    171. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 06; 300(5):555-70. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, International AIDS Society-USA. PMID: 18677028.
      View in: PubMed   Mentions: 351     Fields:    Translation:HumansCells
    172. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Top HIV Med. 2008 Aug-Sep; 16(3):266-85. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD, International AIDS Society-USA. PMID: 19856548.
      View in: PubMed   Mentions: 16     Fields:    
    173. Whither or wither microbicides? Science. 2008 Jul 25; 321(5888):532-4. Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, Lieberman J, Miller CJ, Moore JP, Mosier DE, Richman DD, Schooley RT, Springer MS, Veazey RS, Wainberg MA. PMID: 18653884; PMCID: PMC2835691.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    174. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008 Jul 15; 47(2):266-85. Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD. PMID: 18549313.
      View in: PubMed   Mentions: 155     Fields:    Translation:HumansCells
    175. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology. 2008 Jul 20; 377(1):170-83. Nelson JD, Kinkead H, Brunel FM, Leaman D, Jensen R, Louis JM, Maruyama T, Bewley CA, Bowdish K, Clore GM, Dawson PE, Frederickson S, Mage RG, Richman DD, Burton DR, Zwick MB. PMID: 18499210; PMCID: PMC2493441.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    176. Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS. 2008 Apr 23; 22(7):835-9. Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM. PMID: 18427201; PMCID: PMC2716722.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    177. Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immune Defic Syndr. 2008 Apr 15; 47(5):592-6. Cachay ER, Frost SD, Poon AF, Looney D, Rostami SM, Pacold ME, Richman DD, Little SJ, Smith DM. PMID: 18197122; PMCID: PMC2630881.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    178. Update of the drug resistance mutations in HIV-1: Spring 2008. Top HIV Med. 2008 Apr-May; 16(1):62-8. Johnson VA, Brun-Vezinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 18441382.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    179. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med. 2008 Apr; 14(4):413-20. Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ. PMID: 18376407; PMCID: PMC2630879.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    180. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008 Jun; 82(11):5510-8. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman DD. PMID: 18353964; PMCID: PMC2395184.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    181. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 01; 197(3):411-9. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. PMID: 18248304.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    182. Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop. Antivir Ther. 2008; 13(8):1097-113. Mascolini M, Larder BA, Boucher CA, Richman DD, Mellors JW. PMID: 19195337.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    183. Antibody responses in primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan; 3(1):45-51. Frost SD, Trkola A, Günthard HF, Richman DD. PMID: 19372943.
      View in: PubMed   Mentions: 5     Fields:    
    184. Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations. Antivir Ther. 2008; 13(2):319-34. Mascolini M, Richman D, Larder B, Mellors J, Boucher CA. PMID: 18505183.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    185. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology. 2008 Feb; 134(2):405-15. Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G, Liang TJ, Locarnini S, Martin P, Richman DD, Zoulim F. PMID: 18242209; PMCID: PMC2676233.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    186. Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients. J Virol. 2007 Dec; 81(24):13598-607. Poon AF, Kosakovsky Pond SL, Richman DD, Frost SD. PMID: 17913806; PMCID: PMC2168824.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    187. Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med. 2007 Aug-Sep; 15(4):119-25. Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 17720996.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    188. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis. 2007 Aug 01; 196(3):356-60. Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, Ignacio CC, Frost SD, Richman DD, Little SJ. PMID: 17597449.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    189. Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. J Virol. 2007 Jun; 81(12):6548-62. Dhillon AK, Donners H, Pantophlet R, Johnson WE, Decker JM, Shaw GM, Lee FH, Richman DD, Doms RW, Vanham G, Burton DR. PMID: 17409160; PMCID: PMC1900098.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    190. Evolution of the interferon alpha gene family in eutherian mammals. Gene. 2007 Aug 01; 397(1-2):38-50. Woelk CH, Frost SD, Richman DD, Higley PE, Kosakovsky Pond SL. PMID: 17512142; PMCID: PMC2174272.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimals
    191. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis. 2007 May 01; 195(9):1270-7. Cachay ER, Frost SD, Richman DD, Smith DM, Little SJ. PMID: 17396995.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    192. Adaptation to human populations is revealed by within-host polymorphisms in HIV-1 and hepatitis C virus. PLoS Pathog. 2007 Mar; 3(3):e45. Poon AF, Kosakovsky Pond SL, Bennett P, Richman DD, Leigh Brown AJ, Frost SD. PMID: 17397261; PMCID: PMC1839164.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    193. Key reports from the XV International HIV Drug Resistance Workshop 2006. Antivir Ther. 2007; 12(1):131-45. Mascolini M, Boucher C, Larder B, Mellors J, Richman D. PMID: 17503758.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    194. Advances in the management of HIV-HBV coinfection. Antivir Ther. 2007; 12 Suppl 3:H1. Richman DD. PMID: 18284177.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    195. Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection. Clin Infect Dis. 2007 Feb 01; 44(3):456-8. Smith D, Moini N, Pesano R, Cachay E, Aiem H, Lie Y, Richman D, Little S. PMID: 17205459.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    196. A plea for justice for jailed medical workers. Science. 2006 Nov 10; 314(5801):924-5. Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA. PMID: 17062652.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    197. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006 Nov 10; 355(1):1-5. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. PMID: 16962152.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    198. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006 Aug 16; 296(7):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA, International AIDS Society-USA panel. PMID: 16905788.
      View in: PubMed   Mentions: 199     Fields:    Translation:HumansCells
    199. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Top HIV Med. 2006 Aug-Sep; 14(3):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA, International AIDS Society--USA Panel. PMID: 17016878.
      View in: PubMed   Mentions: 38     Fields:    
    200. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med. 2006 Aug-Sep; 14(3):125-30. Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. PMID: 16946457.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    201. A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay. J Virol Methods. 2006 Oct; 137(1):125-33. Day JR, Martínez LE, Sásik R, Hitchin DL, Dueck ME, Richman DD, Guatelli JC. PMID: 16876264.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    202. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol. 2006 Jun 23; 2(6):e62. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ. PMID: 16789820; PMCID: PMC1480537.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    203. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006 Jul; 129(Pt 7):1872-83. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. PMID: 16735456.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    204. Antiviral drug resistance. Antiviral Res. 2006 Sep; 71(2-3):117-21. Richman DD. PMID: 16621040.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    205. Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol. 2006 Mar; 80(6):3030-41. Yuste E, Sanford HB, Carmody J, Bixby J, Little S, Zwick MB, Greenough T, Burton DR, Richman DD, Desrosiers RC, Johnson WE. PMID: 16501112; PMCID: PMC1395451.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    206. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development. Chem Biol. 2006 Jan; 13(1):69-79. Kumar S, Choi WT, Dong CZ, Madani N, Tian S, Liu D, Wang Y, Pesavento J, Wang J, Fan X, Yuan J, Fritzsche WR, An J, Sodroski JG, Richman DD, Huang Z. PMID: 16426973.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    207. The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005. Antivir Ther. 2006; 11(5):653-65. Boucher C, Larder B, Mellors J, Richman D. PMID: 16964836.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    208. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A. 2005 Dec 20; 102(51):18514-9. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman DD. PMID: 16339909; PMCID: PMC1310509.
      View in: PubMed   Mentions: 194     Fields:    Translation:HumansCells
    209. Update of the drug resistance mutations in HIV-1: Fall 2005. Top HIV Med. 2005 Oct-Nov; 13(4):125-31. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD. PMID: 16304457.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    210. HIV drug resistance acquired through superinfection. AIDS. 2005 Aug 12; 19(12):1251-6. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ. PMID: 16052079.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    211. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet. 2005 Aug 13-19; 366(9485):549-55. Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. PMID: 16099290; PMCID: PMC1894952.
      View in: PubMed   Mentions: 248     Fields:    Translation:HumansCells
    212. HIV superinfection. J Infect Dis. 2005 Aug 01; 192(3):438-44. Smith DM, Richman DD, Little SJ. PMID: 15995957.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    213. Codon volatility does not reflect selective pressure on the HIV-1 genome. Virology. 2005 Jun 05; 336(2):137-43. Pillai SK, Kosakovsky Pond SL, Woelk CH, Richman DD, Smith DM. PMID: 15892955.
      View in: PubMed   Mentions: 7     Fields:    Translation:Cells
    214. Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study). Clin Infect Dis. 2005 Jul 01; 41(1):92-9. Zolopa AR, Lazzeroni LC, Rinehart A, Vezinet FB, Clavel F, Collier A, Conway B, Gulick RM, Holodniy M, Perno CF, Shafer RW, Richman DD, Wainberg MA, Kuritzkes DR. PMID: 15937768.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    215. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. AIDS Res Hum Retroviruses. 2005 May; 21(5):343-57. Daar ES, Richman DD. PMID: 15929696.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    216. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol. 2005 May; 79(10):6523-7. Frost SD, Liu Y, Pond SL, Chappey C, Wrin T, Petropoulos CJ, Little SJ, Richman DD. PMID: 15858036; PMCID: PMC1091710.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCellsPHPublic Health
    217. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 162     Fields:    Translation:HumansCells
    218. Update of the Drug Resistance Mutations in HIV-1: 2005. Top HIV Med. 2005 Mar-Apr; 13(1):51-7. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, Schapiro J, Telenti A, Richman D. PMID: 15849371.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    219. A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575. AIDS. 2005 Feb 18; 19(3):295-302. Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman DD, California Collaborative Treatment Group. PMID: 15718840.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    220. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol. 2005 Feb; 79(3):1734-42. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. PMID: 15650198; PMCID: PMC544119.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    221. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol. 2005 Jan; 79(2):860-8. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ. PMID: 15613314; PMCID: PMC538553.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    222. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum Antibodies. 2005; 14(3-4):101-13. Crooks ET, Moore PL, Richman D, Robinson J, Crooks JA, Franti M, Schülke N, Binley JM. PMID: 16720980; PMCID: PMC2630880.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    223. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med. 2004 Dec 20; 200(12):1547-57. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman DD, McMichael AJ, Jones EY, Rowland-Jones SL. PMID: 15596521; PMCID: PMC2212004.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    224. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses. 2004 Nov; 20(11):1210-22. Woelk CH, Ottones F, Plotkin CR, Du P, Royer CD, Rought SE, Lozach J, Sasik R, Kornbluth RS, Richman DD, Corbeil J. PMID: 15588343.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    225. Update of the drug resistance mutations in HIV-1: 2004. Top HIV Med. 2004 Oct-Nov; 12(4):119-24. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD. PMID: 15516709.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    226. Incidence of HIV superinfection following primary infection. JAMA. 2004 Sep 08; 292(10):1177-8. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. PMID: 15353529.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    227. The prostate as a reservoir for HIV-1. AIDS. 2004 Jul 23; 18(11):1600-2. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ. PMID: 15238781.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    228. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004 Jul 14; 292(2):251-65. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 15249575.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    229. The prevalence of antiretroviral drug resistance in the United States. AIDS. 2004 Jul 02; 18(10):1393-401. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA. PMID: 15199315.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    230. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol. 2004 May; 11(5):435-42. Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. PMID: 15098018.
      View in: PubMed   Mentions: 339     Fields:    Translation:Cells
    231. Benefits and limitations of testing for resistance to HIV drugs. J Antimicrob Chemother. 2004 Apr; 53(4):555-7. Richman DD. PMID: 15014064.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    232. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol. 2004 Mar; 78(5):2242-6. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ. PMID: 14963120; PMCID: PMC369210.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    233. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004 Feb; 2(2):E20. Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, Dong T, Chesney G, Waters A, Easterbrook P, Dunbar PR, Shepherd D, Cerundolo V, Emery V, Griffiths P, Conlon C, McMichael AJ, Richman DD, Rowland-Jones SL, Appay V. PMID: 14966528; PMCID: PMC340937.
      View in: PubMed   Mentions: 179     Fields:    Translation:HumansCells
    234. Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science. 2004 Jan 16; 303(5656):316. Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA. PMID: 14726576.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    235. HIV evolution and escape. Trans Am Clin Climatol Assoc. 2004; 115:289-303. Richman DD, Little SJ, Smith DM, Wrin T, Petropoulos C, Wong JK. PMID: 17060974; PMCID: PMC2263778.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    236. Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance. Antivir Ther. 2003 Dec; 8(6):489-506. Gallant JE, Gerondelis PZ, Wainberg MA, Shulman NS, Haubrich RH, St Clair M, Lanier ER, Hellmann NS, Richman DD. PMID: 14760883.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    237. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS. 2003 Nov 07; 17(16):2345-9. Gulick RM, Meibohm A, Havlir D, Eron JJ, Mosley A, Chodakewitz JA, Isaacs R, Gonzalez C, McMahon D, Richman DD, Robertson M, Mellors JW. PMID: 14571186.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    238. Drug resistance mutations in HIV-1. Top HIV Med. 2003 Nov-Dec; 11(6):215-21. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, D'Aquila RT, Demeter LM, Kuritzkes DR, Pillay D, Schapiro JM, Telenti A, Richman DD, International AIDS Society-USA Drug Resistance Mutations Group. PMID: 14724329.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    239. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations. J Immunol. 2003 Oct 15; 171(8):3999-4005. Ali A, Pillai S, Ng H, Lubong R, Richman DD, Jamieson BD, Ding Y, McElrath MJ, Guatelli JC, Yang OO. PMID: 14530319.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    240. A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128. HIV Clin Trials. 2003 Sep-Oct; 4(5):287-300. Haas DW, Wilkinson GR, Kuritzkes DR, Richman DD, Nicotera J, Mahon LF, Sutcliffe C, Siminski S, Andersen J, Coughlin K, Clayton EW, Haines J, Marshak A, Saag M, Lawrence J, Gustavson J, Anne Bennett J, Christensen R, Matula MA, Wood AJ, Adult AIDS Clinical Trials Group. PMID: 14583845.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    241. Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel. Top HIV Med. 2003 Jul-Aug; 11(4):150-4. Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Richman DD, International AIDS Society-USA Resistance Testing Guidelines Panel. PMID: 12876334.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    242. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis. 2003 Jul 01; 37(1):113-28. Hirsch MS, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD. PMID: 12830416.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    243. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2. J Infect Dis. 2003 Jun 01; 187(11):1735-47. Zaunders JJ, Moutouh-de Parseval L, Kitada S, Reed JC, Rought S, Genini D, Leoni L, Kelleher A, Cooper DA, Smith DE, Grey P, Estaquier J, Little S, Richman DD, Corbeil J. PMID: 12751031.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    244. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS. 2003 May 02; 17(7):F11-6. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ, Petropoulos CJ, Richman DD, Wong JK. PMID: 12700477.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    245. Drug resistance mutations in HIV-1. Top HIV Med. 2003 May-Jun; 11(3):92-6. D'Aquila RT, Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. PMID: 12837968.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    246. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A. 2003 Apr 01; 100(7):4144-9. Richman DD, Wrin T, Little SJ, Petropoulos CJ. PMID: 12644702; PMCID: PMC153062.
      View in: PubMed   Mentions: 631     Fields:    Translation:HumansCells
    247. A new perspective on V3 phenotype prediction. AIDS Res Hum Retroviruses. 2003 Feb; 19(2):145-9. Pillai S, Good B, Richman D, Corbeil J. PMID: 12643277.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    248. Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res Hum Retroviruses. 2003 Feb; 19(2):117-23. Sheeter D, Du P, Rought S, Richman D, Corbeil J. PMID: 12639247.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    249. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003 Feb 15; 187(4):683-6. Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, Richman DD, Little SJ. PMID: 12599087.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    250. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS. 2003 Jan 03; 17(1):53-63. Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson C, Borellini F, Lazar R, Hege KM. PMID: 12478069.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    251. Drug Resistance Mutations in HIV-1. Top HIV Med. 2002 Nov-Dec; 10(5):21-25. D'Aquila RT, International AIDS Society-USA , Schapiro JM, Brun-Vézinet F, Clotet B, Conway B, Demeter LM, Grant RM, Johnson VA, Kuritzkes DR, Loveday C, Shafer RW, Richman DD. PMID: 12717052.
      View in: PubMed   Mentions: 15     Fields:    
    252. Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations. Antimicrob Agents Chemother. 2002 Nov; 46(11):3613-6. Uckun FM, Pendergrass S, Venkatachalam TK, Qazi S, Richman D. PMID: 12384373; PMCID: PMC128707.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    253. The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis. AIDS. 2002 Oct 18; 16(15):F33-40. Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA, California Collaborative Treatment Group. PMID: 12370520.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    254. Baseline predictors of CD4 T-lymphocyte recovery with combination antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31(1):20-6. Bennett KK, DeGruttola VG, Marschner IC, Havlir DV, Richman DD. PMID: 12352146.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    255. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002 Aug 08; 347(6):385-94. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. PMID: 12167680.
      View in: PubMed   Mentions: 302     Fields:    Translation:HumansCells
    256. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002 Jul 10; 288(2):222-35. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 12095387.
      View in: PubMed   Mentions: 136     Fields:    Translation:Humans
    257. A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):699-704. Pollard RB, Tierney C, Havlir D, Tebas P, Fox L, Smeaton L, Richman D, Friedland GH. PMID: 12167276.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    258. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy. Mol Ther. 2002 Jun; 5(6):788-97. Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM. PMID: 12027564.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCellsCTClinical Trials
    259. Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. J Virol. 2002 Jun; 76(12):5966-73. Estaquier J, Lelièvre JD, Petit F, Brunner T, Moutouh-De Parseval L, Richman DD, Ameisen JC, Corbeil J. PMID: 12021329; PMCID: PMC136220.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    260. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002 Apr; 8(4):379-85. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. PMID: 11927944.
      View in: PubMed   Mentions: 549     Fields:    Translation:HumansCells
    261. Dynamics of T cell responses in HIV infection. J Immunol. 2002 Apr 01; 168(7):3660-6. Appay V, Papagno L, Spina CA, Hansasuta P, King A, Jones L, Ogg GS, Little S, McMichael AJ, Richman DD, Rowland-Jones SL. PMID: 11907132.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    262. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA. PMID: 11807299.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    263. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J Virol. 2002 Jan; 76(1):185-94. Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW. PMID: 11739684; PMCID: PMC135696.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    264. Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor. Antivir Ther. 2001 Jun; 6(2):83-8. Richman DD. PMID: 11491420.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    265. HIV chemotherapy. Nature. 2001 Apr 19; 410(6831):995-1001. Richman DD. PMID: 11309630.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansAnimalsCells
    266. Principles of HIV resistance testing and overview of assay performance characteristics. Antivir Ther. 2000 Mar; 5(1):27-31. Richman DD. PMID: 10846590.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    267. Normal physiology and HIV pathophysiology of human T-cell dynamics. J Clin Invest. 2000 Mar; 105(5):565-6. Richman DD. PMID: 10712427; PMCID: PMC292457.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    268. The implications of drug resistance for strategies of combination antiviral chemotherapy. Antiviral Res. 1996 Jan; 29(1):31-3. Richman DD. PMID: 8721540.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    Douglas's Networks
    Concepts (624)
    Derived automatically from this person's publications.
    _
    Co-Authors (89)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _